SRPT

Sarepta Therapeutics Stock Price

97.50
0.58 (0.6%)
Upgrade to Real-Time
Afterhours (Closed)
97.50
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.58 0.6% 97.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
95.76 95.45 98.79 98.24 96.92
Bid Price Ask Price Spread News
97.01 97.90 0.89 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
21,737 1,445,129 $ 96.82 $ 139,912,391 2,864,238 78.06 - 181.83
Last Trade Time Type Quantity Stock Price Currency
19:59:48 formt 124 $ 97.50 USD

Sarepta Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 7.69B 78.91M 66.75M $ 380.83M $ -351.78M -9.68 -12.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sarepta Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRPT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week89.95103.0489.4194.892,865,1137.558.39%
1 Month175.76180.4182.2593.755,177,848-78.26-44.53%
3 Months140.36181.8382.25107.352,259,226-42.86-30.54%
6 Months167.85181.8382.25117.221,355,046-70.35-41.91%
1 Year121.80181.8378.06121.581,120,695-24.30-19.95%
3 Years63.09181.8350.68115.421,243,58534.4154.54%
5 Years12.67181.838.0063.751,957,34184.83669.53%

Sarepta Therapeutics Description

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.


Your Recent History
NASDAQ
SRPT
Sarepta Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.